Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 13/20 | 1.00 |
| ▸ | DPP4 | P27487 | 4/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 1.00 |
| ▸ | IDH1 | O75874 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | UGT1A1 | P22309 | 1/20 | 1.00 |
| ▸ | ABCC1 | P33527 | 1/20 | 1.00 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 1.00 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.60 |
| ▸ | CTSL | P07711 | 1/20 | 0.60 |
| ▸ | CTSB | P07858 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Licoagrochacone A SCHEMBL30383634 | 1.00 | PTPN1 (1.00) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| Licoagrochacone A SCHEMBL29929441 | 1.00 | PTPN1 (1.00) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| Licoagrochacone A SCHEMBL4906294 | 1.00 | PTPN1 (1.00) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL24026322 | 0.92 | PTPN1 (0.85) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL7191524 | 0.92 | PTPN1 (1.00) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL7191527 | 0.92 | PTPN1 (1.00) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| Licoagrochacone A SCHEMBL25196053 | 0.89 | PTPN1 (0.80) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL7187524 | 0.88 | PTPN1 (0.79) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL7187519 | 0.88 | PTPN1 (0.79) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL7178841 | 0.88 | PTPN1 (0.78) | PTPN1DPP4ABCG2IDH1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3432 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115252599-B | Application of licochalcone A and composition of glabridin and licochalcone A in preparation of medicines for treating colorectal cancer | 宁夏医科大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122067647-A | Prediction and depth verification integration method for traditional Chinese medicine compound action mechanism research | 国药集团德众（佛山）药业有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122036553-A | Compound, nanoparticle, composition and application thereof | 北京大学第三医院（北京大学第三临床医学院） | 2026-05-15 | — | — | CN | claimed |
| CN-122005513-A | Anti-tumor and/or anti-iron death small molecule composition and application thereof | 北京慧宝源生物技术股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| WO-2026087103-A1 | COMBINATION OF RETINOL, ALKYLAMIDOTHIAZOLES AND FLAVONOIDS FOR IMPROVING ACTIVE SUBSTANCE STABILIZATION | BEIERSDORF AG (DE) | 2026-04-30 | — | — | WO | claimed |
| EP-4713433-A2 | LIVER ORGANOIDS WITH INTRAHEPATIC SYMPATHETIC NERVES, AND METHODS OF USE THEREOF | Children's Hospital Medical Center (US) | 2026-03-25 | — | — | EP | claimed |
| US-20260061019-A1 | Topical Compositions For Regulating Sebum Production | ELC MAN LLC (US) | 2026-03-05 | — | — | US | claimed |
| EP-4157208-B1 | MINERAL-OIL-FREE W/O EMULSION WITH A VARIABLE CONSISTENCY | BEIERSDORF AG (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4701742-A1 | RETINOL-CONTAINING COSMETIC PREPARATION WITH GOOD SKIN COMPATIBILITY | Beiersdorf AG (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4701743-A1 | RETINOL-CONTAINING COSMETIC PREPARATION WITH GOOD STABILITY, SKIN COMPATIBILITY AND EFFECTIVENESS | Beiersdorf AG (DE) | 2026-03-04 | — | — | EP | claimed |
| CN-1520811-A | External composition containing oil-soluble licorice extract and method for stabilizing the same | 丸善制药株式会社 | 2004-08-18 | — | — | CN | claimed |
| EP-1440688-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGANDS AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2004-07-28 | — | — | EP | claimed |
| US-20030199581-A1 | Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid (\"AKBA\") industrial manufacture and uses | BIOPHYSICA, INC. | 2003-10-23 | — | — | US | claimed |
| WO-2003077860-A2 | BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES | BIOPHYSICA, INC. (US) | 2003-09-25 | — | — | WO | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| US-6603046-B1 | The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. | LICA PHARMACEUTICALS A/S (DK) | 2003-08-05 | — | — | US | claimed |
| US-6486203-B1 | Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors | CORNELL RESEARCH FOUNDATION, INC. | 2002-11-26 | — | — | US | claimed |
| EP-0634927-B1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | LICA PHARMACEUTICALS AS (DK) | 2001-07-04 | — | — | EP | claimed |
| WO-1995006628-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1995-03-09 | — | — | WO | claimed |
| CN-1095590-A | By parasite or bacterial treatment of diseases and prevention | STATENS SERUMINSTITUT (DK) | 1994-11-30 | — | — | CN | claimed |